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Objectives and Methodology of the Consensus Process
Introduction
Surprising variation continues to be found in the management of individual patients with identi-
cal conditions. Variations arise not only from country to country but often from one hospital to
another in the same city. Widely accepted standards of care and international consensus state-
ments to facilitate this process, particularly in less common diseases, are needed. These state-
ments are also part of the movement toward evidence-based medicine, predetermined health
care paths, managed care, and cost-benefit analysis. Such consensus documents help maintain
international medical standards and are particularly valuable when national health care systems
have evolved along different paths and to different levels. Consensus statements help promote a
uniform high level of medical care across different countries.
Why should a consensus document make any difference? Experience has shown that such docu-
ments are increasingly referred to to resolve conflicts in the medical literature. This is only true
if the process whereby such docurrients are developed is credible and if the document is devel-
oped by recognized international societies rather than emanating from a group of individuals.
Essential Criteria
To be credible and achieve these functions, a consensus process should ideallyfulfill the follow-
ing criteria:
• Objectives must be clearly defined.
• The scope, particularly in terms of the patient population whose management it addresses,
must be clearly set out.
• The methodology and sources of information used to arrive at its conclusions must be
defined, and the level and breadth of consultation and subsequent endorsement should be
clearly spelled out.
• Existing guidelines should be acknowledged and discussed.
• Participants, both individuals and societies, must be described and represent all relevant key
disciplines. The breadth of consultation should be described, and minority views should be
identified and represented.
• Potential health benefits, risks, and costs incurred from the recommended management should
be assessed.
History of the Consensus Process
The current process, concerned with the management of patients with atherosclerotic arterial
occlusive disease in the legs, arose from the European Consensus on Critical Leg Ischaemia,
which began as a series of international workshops in 1988 and reached fruition with the publi-
cation of the Second European Consensus at the end of 1991. 1 This work was confined to
Europe because it was believed that the problems inherent in a multidisciplinary and multina-
tional process made a wider geographical coverage impractical at that stage. It was also limited
to the more severe stages of ischemia, for that was the focus of much controversy and wider
variations in management. There is now a need for broader clinical and geographical focus,
which has encouraged us to revise and expand it on a wide trans-Atlantic and societal basis and
to include the management of patients with all degrees of severity of atherosclerotic disease in
the legs.
Objectives of the Document
The objectives of the current document can be summarized as follows:
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• Formulate a consensus expert opinion by representatives from key professional societies
involved in the management ofleg ischemia and refine that opinion with frequent input from
the societies.
• Evaluate best available evidence and set out appropriate management algorithms to achieve
the optimal outcome for the patient.
• Standardize classification and terminology.
• Set guidelines for reporting and evaluating clinical studies, including outcome assessment.
• Encourage a multidisciplinary approach from all groups skilled in the management of these
patients, induding angiologists, vascular physicians, vascular surgeons, inrerventional radiolo-
gists, hematologists, diabctologists, and cardiologists.
• Identify and explore areas of genuine controversy that need resolution.
Organization of the Document
To achieve an in-depth consideration of the topic, it was decided to confine this Consensus doc-
ument to peripheral arterial occlusive disease (PAD) because of atherosclerosis affecting the legs.
Ischemia of the arms and other peripheral vessels is therefore excluded, as is occlusive arterial
disease due to much rarer pathological conditions such as Buerger's disease or vasculitis.
However, these other conditions are considered in the differential diagnosis section. The. docu-
ment is confined to symptomatic patients, although the importance of asymptomatic PAD in
terms of cardiovascular risk is recognized. This is dealt with in Epidemiology (p 55).
The document itself is divided into four principal sections: an introduction followed by sections
on intermittent claudication, acute limb ischemia, and critical limb ischemia. For reasons dis-
cussed in detail at the beginning of the section on chronic critical limb ischemia (CLI), this
term is used to include all patients with rest pain, gangrene, or ulcers predominantly due to
arterial disease. This was done to ensure that all patients with significant PAD attributable to
atherosclerosis are considered in one of the sections. The arguments tor and against a more
restricted definition of critical limb ischemia are also considered at the beginning of Section D
(Critical Limb Ischemia) . The definitions and classifications of intermittem claudication and
acute limb ischemia are also considered at the beginning of the Sections C and D, respectively.
The epidemiology of all degrees of severity of PAD is discussed in a single chapter in the intro-
ductory Section A. In view of the recent rapid evolution and problems associated with national
health care provisions, it was thought necessary to consider in detail issues relating to outcome
measures of effectiveness and related socioeconomic issues. The general principles of these rela-
tively new disciplines are also discussed in the introductory section, but the application of these
principles is integrated into the clinical chapters of the appropriate parts of Sections B, C, and
D. Outcome assessment methodology and clinical trials issues arc clearly related but in this doc -
ument are discussed under separate sections. This is because outcomes assessment is a more gen-
eral process that ideally should be practiced in all centers treating patients with PAD, whereas
the chapters on Clinical Trials Issues focus on the special circumstances of clinical trials for pub-
lication.
The Consensus Process
The current process began in 1996 with meetings of the Consensus Working Group, which
consisted of liaison members approved by each participating society listed at the front of the
document. Three additional members were chosen for their expertise in health economy and
outcome assessment. The Consensus 'Working Group reviewed the literature and, after extensive
correspondence and a series of meetings, proposed a series of draft documents with clear recom-
mendations to form the basis of further consultations. Each participating society set up its OW11
Advisory Group within the society to review and comment on these draft consensus documents.
The liaison member from each society then took these views back to the Consensus Working
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Group, where all of the amendments, additions, and alterations suggested by each participating
society were discussed at a further series of meetings, and the final Consensus Document was
agreed on.
The participating societies were then again invited to review the final document and endorse it if
they agreed with its contents. If an individual participating society did not accept any specific
recommendation, this is clearly indicated in the final document. Therefore, except where such
specific exclusions are indicated, this Consensus Document represents the view of all of the par-
ticipating societies.
The criteria tor a credible consensus process, listed above, were clearly adhered to. The refer-
ences in the document are intended to be comprehensive rather than exhaustive. Not a\\ of the
publications considered by the participating societies in the Consensus Working Group are nec-
essarily quoted, but all of the key references are included, particularly in the areas of controversy,
A deliberate attempt was made to incorporate in the final Consensus Document very useful
work recently performed by other, similar groups dealing with more specifictopics. In particu-
lar, we relied on the "Consensus Document on Thrombolysis in the Management of Leg
Ischaemia," "Guidelines for Peripheral Percutaneous Translurninal Angioplasty," and
"Suggested Standards and Reports Dealing with Lower Extremity Ischemia."2,3,4 The debt
owed to these and other documents is clearly indicated in the text.
The Consensus Working Group gave serious consideration to using a formal assessment of every
clinical study quoted to classify its weight as evidence, adopting a system similar to that used by
the National Institutes of Health Consensus Development Conferences, who defined "levels of
evidence" and "grades of recommendation." 5,6 Such a system means that firm recommenda-
tions are based only on the results of rigorously controlled investigations. The Working Group
rejected such a formal process, principally because formal proof and studies with high levels of
evidence were typically lacking in this area. All recommendations are based on the best available
evidence, and where insufficient evidence exists, critical issues have been identified. The text and
the wording of recommendations in the Consensus Document clearly attempt to identify the
quality of the evidence available to support individual recommendations.
Caveat
Any interpretation of the recommendations should be in the context of the facilities and exper-
tise available in individual institutions. Often the recommendations aim at an optimal scenario in
the full realization that this may not be achievable in many hospitals. Nevertheless, it was
believed that there would be some purpose in setting out an ideal aim. On other occasions, the
wording of the recommendation makes clear that a minimum acceptable level is meant.
Irrespective of specific recommendations, all of the societies participating in this process agree
that the treatment of every patient must of necessity be individualized. The physicians involved
need to take into account individual circumstances and influences that must quite properly over-
ride any recommendations in this document, which of necessity must be generalizations. We
envisage this document forming the basis of individual local protocols or guidelines.
Finally, in the course of developing this document, it became clear that in some key areas no
strong opinions are held because of absence ofsufficient relevant hard data. These "Critical
Issues" have been identified as such in the document. Consensus documents such as this must,
of necessity, be ephemeral. The scientific process was completed in the middle of 1999 and rep-
resents the up-to-date view at that time. It must be accepted that further evidence will make
some of the conclusions in the document out of date and incorrect in subsequent years. The
participating societies therefore commit themselves to continuing the update process (Figure 1).
84 Ai Objectives and Methodology of the Consensus Process
JOURNAL OF VASCULAR SURGERY
January2000
Figure 1: Consensus methodology.
Final Draft
Document for
Approval
Individual Societies
Final Draft
Document for
Comments
//
Advisory Group
of Societies
~ /* .Reviewed In '"'~ Sections \
Working
Group
Societies'
Representative
on
Several
Intermediatedraft
Documenlll
References
1. Second European Consensus Document on Chronic Critical Leg Ischaemia. Eur J Vase Surg 1992;6 (Suppl A):1-28.
2. Working Party on Thrombolysis. Thrombolysis in the management of lower limb peripheral arteria/ occlusion-A consensus docu-
ment. Am J Cardiel 1998;81 :207-218.
3. Pentecost MJ, Criqui MH, Dorms G, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta
and lower extremity vessels. Circulation 1994;89(1):511-531.
4. Rutherford RB, Baker TD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised ver-
sion. TVase Surg 1997;26(3):517-538.
5. Sackett DL, Oxman AD, Guyatt GH. Users' guide to the medical literature.T, How to get started. JAMA 1993;270:2093-2095.
6. Guyatt GH, Sackett DL, Cook DJ, er al, Users' guide to the medica/literature. n.How to use an article about therapy or proven-
tion. JAMA 1993;270:2598-2601.
